{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T13:52:44Z","timestamp":1769694764245,"version":"3.49.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Cardio Med"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s11936-019-0797-1","type":"journal-article","created":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T07:02:35Z","timestamp":1575874955000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Management of Heart Failure and Cardiogenic Shock in Pregnancy"],"prefix":"10.1007","volume":"21","author":[{"given":"Shilpa","family":"Sharma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunu S.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,12,9]]},"reference":[{"key":"797_CR1","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1001\/jama.2018.11652","volume":"320","author":"MC Lu","year":"2018","unstructured":"Lu MC. Reducing maternal mortality in the United States. Jama. 2018;320:1237\u20138.","journal-title":"Jama."},{"key":"797_CR2","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1056\/NEJMp1810649","volume":"379","author":"S Mann","year":"2018","unstructured":"Mann S, Hollier LM, McKay K, Brown H. What we can do about maternal mortality - and how to do it quickly. N Engl J Med. 2018;379:1689\u201391.","journal-title":"N Engl J Med"},{"key":"797_CR3","doi-asserted-by":"crossref","unstructured":"Honigberg MC, Givertz MM. Peripartum cardiomyopathy. Bmj. 2019;364:k5287. Thorough, contemporary overview of peripartum cardiomyopathy epidemiology, pathogenesis, clinical presentation, prognosis, and management.","DOI":"10.1136\/bmj.k5287"},{"key":"797_CR4","doi-asserted-by":"crossref","unstructured":"Hameed AB, Lawton ES, McCain CL, Morton CH, Mitchell C, Main EK, Foster E. Pregnancy-related cardiovascular deaths in california: Beyond peripartum cardiomyopathy. American journal of obstetrics and gynecology. 2015;213:379 e371\u2013310.","DOI":"10.1016\/j.ajog.2015.05.008"},{"key":"797_CR5","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/10641955.2016.1242606","volume":"36","author":"J Banayan","year":"2017","unstructured":"Banayan J, Rana S, Mueller A, Tung A, Ramadan H, Arany Z, et al. Cardiogenic shock in pregnancy: analysis from the national inpatient sample. Hypertension in pregnancy. 2017;36:117\u201323.","journal-title":"Hypertension in pregnancy"},{"issue":"11","key":"797_CR6","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.cjca.2017.08.022","volume":"33","author":"Justin A. Ezekowitz","year":"2017","unstructured":"Ezekowitz JA, O\u2019Meara E, McDonald MA, Abrams H, Chan M, Ducharme A, Giannetti N, Grzeslo A, Hamilton PG, Heckman GA, Howlett JG, Koshman SL, Lepage S, McKelvie RS, Moe GW, Rajda M, Swiggum E, Virani SA, Zieroth S, Al-Hesayen A, Cohen-Solal A, D\u2019Astous M, De S, Estrella-Holder E, Fremes S, Green L, Haddad H, Harkness K, Hernandez AF, Kouz S, LeBlanc MH, Masoudi FA, Ross HJ, Roussin A, Sussex B. 2017 comprehensive update of the canadian cardiovascular society guidelines for the management of heart failure. The Canadian journal of cardiology. 2017;33:1342\u20131433.","journal-title":"Canadian Journal of Cardiology"},{"key":"797_CR7","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.jacc.2016.05.048","volume":"68","author":"U Elkayam","year":"2016","unstructured":"Elkayam U, Goland S, Pieper PG, Silverside CK. High-risk cardiac disease in pregnancy: part i. J Am Coll Cardiol. 2016;68:396\u2013410.","journal-title":"J Am Coll Cardiol"},{"key":"797_CR8","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1136\/heartjnl-2016-310599","volume":"104","author":"AM Jackson","year":"2018","unstructured":"Jackson AM, Dalzell JR, Walker NL, Coats CJ, Jhund PS, Petrie MC. Peripartum cardiomyopathy: diagnosis and management. Heart. 2018;104:779\u201386.","journal-title":"Heart."},{"issue":"9","key":"797_CR9","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1002\/ejhf.586","volume":"18","author":"Johann Bauersachs","year":"2016","unstructured":"Bauersachs J, Arrigo M, Hilfiker-Kleiner D, Veltmann C, Coats AJ, Crespo-Leiro MG, De Boer RA, van der Meer P, Maack C, Mouquet F, Petrie MC, Piepoli MF, Regitz-Zagrosek V, Schaufelberger M, Seferovic P, Tavazzi L, Ruschitzka F, Mebazaa A, Sliwa K. Current management of patients with severe acute peripartum cardiomyopathy: Practical guidance from the heart failure association of the european society of cardiology study group on peripartum cardiomyopathy. European journal of heart failure. 2016;18:1096\u20131105.","journal-title":"European Journal of Heart Failure"},{"key":"797_CR10","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jchf.2013.04.011","volume":"1","author":"DP Kao","year":"2013","unstructured":"Kao DP, Hsich E, Lindenfeld J. Characteristics, adverse events, and racial differences among delivering mothers with peripartum cardiomyopathy. JACC Heart failure. 2013;1:409\u201316.","journal-title":"JACC Heart failure"},{"key":"797_CR11","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.jacc.2016.05.050","volume":"68","author":"U Elkayam","year":"2016","unstructured":"Elkayam U, Goland S, Pieper PG, Silversides CK. High-risk cardiac disease in pregnancy: part ii. J Am Coll Cardiol. 2016;68:502\u201316.","journal-title":"J Am Coll Cardiol"},{"key":"797_CR12","doi-asserted-by":"crossref","unstructured":"Arrigo M, Blet A, Mebazaa A. Bromocriptine for the treatment of peripartum cardiomyopathy: welcome on board. European heart journal. 2017;38:2680-2682. Introduces a helpful mnemonic to categorize medical therapies for peripartum cardiomyopathy.","DOI":"10.1093\/eurheartj\/ehx428"},{"key":"797_CR13","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1136\/hrt.2009.179218","volume":"96","author":"H Yamac","year":"2010","unstructured":"Yamac H, Bultmann I, Sliwa K, Hilfiker-Kleiner D. Prolactin: a new therapeutic target in peripartum cardiomyopathy. Heart. 2010;96:1352\u20137.","journal-title":"Heart."},{"key":"797_CR14","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/s00395-013-0366-9","volume":"108","author":"A Haghikia","year":"2013","unstructured":"Haghikia A, Podewski E, Libhaber E, Labidi S, Fischer D, Roentgen P, et al. Phenotyping and outcome on contemporary management in a German cohort of patients with peripartum cardiomyopathy. Basic Res Cardiol. 2013;108:366.","journal-title":"Basic Res Cardiol"},{"key":"797_CR15","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1161\/CIRCULATIONAHA.109.901496","volume":"121","author":"K Sliwa","year":"2010","unstructured":"Sliwa K, Blauwet L, Tibazarwa K, Libhaber E, Smedema JP, Becker A, et al. Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy: a proof-of-concept pilot study. Circulation. 2010;121:1465\u201373.","journal-title":"Circulation."},{"key":"797_CR16","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1093\/eurheartj\/ehx355","volume":"38","author":"D Hilfiker-Kleiner","year":"2017","unstructured":"Hilfiker-Kleiner D, Haghikia A, Berliner D, Vogel-Claussen J, Schwab J, Franke A, et al. Bromocriptine for the treatment of peripartum cardiomyopathy: a multicentre randomized study. Eur Heart J. 2017;38:2671\u20139.","journal-title":"Eur Heart J"},{"key":"797_CR17","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1161\/CIRCULATIONAHA.115.020491","volume":"133","author":"Z Arany","year":"2016","unstructured":"Arany Z, Elkayam U. Peripartum cardiomyopathy. Circulation. 2016;133:1397\u2013409.","journal-title":"Circulation."},{"key":"797_CR18","doi-asserted-by":"crossref","unstructured":"Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, Blomstrom-Lundqvist C, Cifkova R, De Bonis M, Iung B, Johnson MR, Kintscher U, Kranke P, Lang IM, Morais J, Pieper PG, Presbitero P, Price S, Rosano GMC, Seeland U, Simoncini T, Swan L, Warnes CA. 2018 ESC guidelines for the management of cardiovascular diseases during pregnancy. European heart journal. 2018;39:3165-3241. Most updated European Society of Cardiology guidelines for the management of peripartum cardiomyopathy.","DOI":"10.5603\/KP.2019.0049"},{"key":"797_CR19","doi-asserted-by":"crossref","unstructured":"Bozkurt B, Colvin M, Cook J, Cooper LT, Deswal A, Fonarow GC, Francis GS, Lenihan D, Lewis EF, McNamara DM, Pahl E, Vasan RS, Ramasubbu K, Rasmusson K, Towbin JA, Yancy C. Current diagnostic and treatment strategies for specific dilated cardiomyopathies: a scientific statement from the American heart association. Circulation. 2016;134:e579-e646. Most updated American Heart Association guidelines for the management of peripartum cardiomyopathy.","DOI":"10.1161\/CIR.0000000000000455"},{"key":"797_CR20","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1172\/JCI64365","volume":"123","author":"J Halkein","year":"2013","unstructured":"Halkein J, Tabruyn SP, Ricke-Hoch M, Haghikia A, Nguyen NQ, Scherr M, et al. Microrna-146a is a therapeutic target and biomarker for peripartum cardiomyopathy. J Clin Invest. 2013;123:2143\u201354.","journal-title":"J Clin Invest"},{"key":"797_CR21","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nature11040","volume":"485","author":"IS Patten","year":"2012","unstructured":"Patten IS, Rana S, Shahul S, Rowe GC, Jang C, Liu L, et al. Cardiac angiogenic imbalance leads to peripartum cardiomyopathy. Nature. 2012;485:333\u20138.","journal-title":"Nature."},{"key":"797_CR22","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/nrcardio.2015.172","volume":"12","author":"PG Pieper","year":"2015","unstructured":"Pieper PG. Use of medication for cardiovascular disease during pregnancy. Nat Rev Cardiol. 2015;12:718\u201329.","journal-title":"Nat Rev Cardiol"},{"issue":"2","key":"797_CR23","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1161\/HYPERTENSIONAHA.112.196352","volume":"60","author":"Marina Bullo","year":"2012","unstructured":"Bullo M, Tschumi S, Bucher BS, Bianchetti MG, Simonetti GD. Pregnancy outcome following exposure to angiotensin-converting enzyme inhibitors or angiotensin receptor antagonists: a systematic review. Hypertension (Dallas, Tex. : 1979). 2012;60:444\u2013450.","journal-title":"Hypertension"},{"issue":"11","key":"797_CR24","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1111\/jch.13397","volume":"20","author":"Lewei Duan","year":"2018","unstructured":"Duan L, Ng A, Chen W, Spencer HT, Lee MS. Beta-blocker subtypes and risk of low birth weight in newborns. Journal of clinical hypertension (Greenwich, Conn.). 2018;20:1603\u20131609.","journal-title":"The Journal of Clinical Hypertension"},{"key":"797_CR25","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ijcard.2014.09.013","volume":"177","author":"TP Ruys","year":"2014","unstructured":"Ruys TP, Maggioni A, Johnson MR, Sliwa K, Tavazzi L, Schwerzmann M, et al. Cardiac medication during pregnancy, data from the ropac. Int J Cardiol. 2014;177:124\u20138.","journal-title":"Int J Cardiol"},{"key":"797_CR26","doi-asserted-by":"crossref","first-page":"58I","DOI":"10.1016\/S0002-9149(98)00473-1","volume":"82","author":"T Chow","year":"1998","unstructured":"Chow T, Galvin J, McGovern B. Antiarrhythmic drug therapy in pregnancy and lactation. Am J Cardiol. 1998;82:58I\u201362I.","journal-title":"Am J Cardiol"},{"key":"797_CR27","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1530\/acta.0.0950540","volume":"95","author":"A Hecker","year":"1980","unstructured":"Hecker A, Hasan SH, Neumann F. Disturbances in sexual differentiation of rat foetuses following spironolactone treatment. Acta Endocrinol. 1980;95:540\u20135.","journal-title":"Acta Endocrinol"},{"key":"797_CR28","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1002\/phar.1795","volume":"36","author":"B Laliberte","year":"2016","unstructured":"Laliberte B, Reed BN, Ather A, Devabhakthuni S, Watson K, Lardieri AB, et al. Safe and effective use of pharmacologic and device therapy for peripartum cardiomyopathy. Pharmacotherapy. 2016;36:955\u201370.","journal-title":"Pharmacotherapy."},{"key":"797_CR29","doi-asserted-by":"crossref","unstructured":"Regitz-Zagrosek V, Blomstrom Lundqvist C, Borghi C, Cifkova R, Ferreira R, Foidart JM, Gibbs JS, Gohlke-Baerwolf C, Gorenek B, Iung B, Kirby M, Maas AH, Morais J, Nihoyannopoulos P, Pieper PG, Presbitero P, Roos-Hesselink JW, Schaufelberger M, Seeland U, Torracca L. ESC guidelines on the management of cardiovascular diseases during pregnancy: the task force on the management of cardiovascular diseases during pregnancy of the european society of cardiology (esc). European heart journal. 2011;32:3147\u20133197.","DOI":"10.1093\/eurheartj\/ehr218"},{"key":"797_CR30","volume":"3","author":"D Kolte","year":"2014","unstructured":"Kolte D, Khera S, Aronow WS, Palaniswamy C, Mujib M, Ahn C, et al. Temporal trends in incidence and outcomes of peripartum cardiomyopathy in the United States: a nationwide population-based study. J Am Heart Assoc. 2014;3:e001056.","journal-title":"J Am Heart Assoc"},{"key":"797_CR31","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1055\/s-0036-1592304","volume":"42","author":"H Cohen","year":"2016","unstructured":"Cohen H, Arachchillage DR, Beyer-Westendorf J, Middeldorp S, Kadir RA. Direct oral anticoagulants and women. Semin Thromb Hemost. 2016;42:789\u201397.","journal-title":"Semin Thromb Hemost"},{"key":"797_CR32","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/0002-9378(81)90492-0","volume":"139","author":"J Naulty","year":"1981","unstructured":"Naulty J, Cefalo RC, Lewis PE. Fetal toxicity of nitroprusside in the pregnant ewe. Am J Obstet Gynecol. 1981;139:708\u201311.","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"797_CR33","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1590\/S1516-31802007000200008","volume":"125","author":"Nelson Sass","year":"2007","unstructured":"Sass N, Itamoto CH, Silva MP, Torloni MR, Atallah AN. Does sodium nitroprusside kill babies? A systematic review. Sao Paulo medical journal = Rev Paul Med 2007;125:108\u2013111.","journal-title":"Sao Paulo Medical Journal"},{"key":"797_CR34","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/HCO.0000000000000516","volume":"33","author":"S Goland","year":"2018","unstructured":"Goland S, Elkayam U. Peripartum cardiomyopathy: approach to management. Curr Opin Cardiol. 2018;33:347\u201353.","journal-title":"Curr Opin Cardiol"},{"key":"797_CR35","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/S0140-6736(15)00070-7","volume":"387","author":"BWJ Mol","year":"2016","unstructured":"Mol BWJ, Roberts CT, Thangaratinam S, Magee LA, de Groot CJM, Hofmeyr GJ. Pre-eclampsia. Lancet. 2016;387:999\u20131011.","journal-title":"Lancet."},{"key":"797_CR36","first-page":"349","volume":"38","author":"B Stapel","year":"2017","unstructured":"Stapel B, Kohlhaas M, Ricke-Hoch M, Haghikia A, Erschow S, Knuuti J, et al. Low stat3 expression sensitizes to toxic effects of beta-adrenergic receptor stimulation in peripartum cardiomyopathy. Eur Heart J. 2017;38:349\u201361.","journal-title":"Eur Heart J"},{"key":"797_CR37","doi-asserted-by":"crossref","unstructured":"Maack C, Eschenhagen T, Hamdani N, Heinzel FR, Lyon AR, Manstein DJ, Metzger J, Papp Z, Tocchetti CG, Yilmaz MB, Anker SD, Balligand JL, Bauersachs J, Brutsaert D, Carrier L, Chlopicki S, Cleland JG, de Boer RA, Dietl A, Fischmeister R, Harjola VP, Heymans S, Hilfiker-Kleiner D, Holzmeister J, de Keulenaer G, Limongelli G, Linke WA, Lund LH, Masip J, Metra M, Mueller C, Pieske B, Ponikowski P, Ristic A, Ruschitzka F, Seferovic PM, Skouri H, Zimmermann WH, Mebazaa A. Treatments targeting inotropy. European heart journal. 2018.","DOI":"10.1093\/eurheartj\/ehy600"},{"issue":"6474","key":"797_CR38","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1136\/bmj.290.6474.1079-e","volume":"290","author":"M Ounsted","year":"1985","unstructured":"Ounsted M, Redman CW. Overview of randomised trials of diuretics in pregnancy. British medical journal (Clinical research ed.). 1985;290:1079\u20131080.","journal-title":"BMJ"},{"key":"797_CR39","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.jacc.2018.10.075","volume":"73","author":"DG Halpern","year":"2019","unstructured":"Halpern DG, Weinberg CR, Pinnelas R, Mehta-Lee S, Economy KE, Valente AM. Use of medication for cardiovascular disease during pregnancy: Jacc state-of-the-art review. J Am Coll Cardiol. 2019;73:457\u201376.","journal-title":"J Am Coll Cardiol"},{"key":"797_CR40","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1161\/CIRCHEARTFAILURE.113.000721","volume":"7","author":"RY Loyaga-Rendon","year":"2014","unstructured":"Loyaga-Rendon RY, Pamboukian SV, Tallaj JA, Acharya D, Cantor R, Starling RC, et al. Outcomes of patients with peripartum cardiomyopathy who received mechanical circulatory support. Data from the interagency registry for mechanically assisted circulatory support. Circulation Heart failure. 2014;7:300\u20139.","journal-title":"Circulation Heart failure"},{"key":"797_CR41","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.cjca.2016.10.023","volume":"33","author":"AD Nagpal","year":"2017","unstructured":"Nagpal AD, Singal RK, Arora RC, Lamarche Y. Temporary mechanical circulatory support in cardiac critical care: a state of the art review and algorithm for device selection. The Canadian journal of cardiology. 2017;33:110\u20138.","journal-title":"The Canadian journal of cardiology"},{"issue":"2","key":"797_CR42","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00392-012-0494-5","volume":"102","author":"Marco R. Schroeter","year":"2012","unstructured":"Schroeter MR, Unsold B, Holke K, Schillinger W. Pro-thrombotic condition in a woman with peripartum cardiomyopathy treated with bromocriptine and an impella lp 2.5 heart pump. Clinical research in cardiology : official journal of the German Cardiac Society. 2013;102:155\u2013157.","journal-title":"Clinical Research in Cardiology"},{"key":"797_CR43","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s11936-017-0575-x","volume":"19","author":"AE Fogerty","year":"2017","unstructured":"Fogerty AE. Challenges of anticoagulation therapy in pregnancy. Current treatment options in cardiovascular medicine. 2017;19:76.","journal-title":"Current treatment options in cardiovascular medicine"},{"key":"797_CR44","doi-asserted-by":"crossref","first-page":"S225","DOI":"10.1016\/j.healun.2013.01.571","volume":"32","author":"AH-KD Neumann","year":"2013","unstructured":"Neumann AH-KD, K\u00fchn C, Fegbeutel C, Hilfiker A, Haverich A, Bara C. Prolactin-a new marker for ecmo-related mortality. J Heart Lung Transplant. 2013;32:S225.","journal-title":"J Heart Lung Transplant"},{"key":"797_CR45","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.jacc.2015.06.1309","volume":"66","author":"DM McNamara","year":"2015","unstructured":"McNamara DM, Elkayam U, Alharethi R, Damp J, Hsich E, Ewald G, et al. Clinical outcomes for peripartum cardiomyopathy in North America: results of the IPAC study (investigations of pregnancy-associated cardiomyopathy). J Am Coll Cardiol. 2015;66:905\u201314.","journal-title":"J Am Coll Cardiol"},{"key":"797_CR46","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.healun.2011.11.018","volume":"31","author":"K Rasmusson","year":"2012","unstructured":"Rasmusson K, Brunisholz K, Budge D, Horne BD, Alharethi R, Folsom J, et al. Peripartum cardiomyopathy: post-transplant outcomes from the united network for organ sharing database. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2012;31:180\u20136.","journal-title":"The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation"},{"key":"797_CR47","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.tcm.2018.07.012","volume":"29","author":"K Stergiopoulos","year":"2019","unstructured":"Stergiopoulos K, Lima FV. Peripartum cardiomyopathy-diagnosis, management, and long term implications. Trends in cardiovascular medicine. 2019;29:164\u201373.","journal-title":"Trends in cardiovascular medicine"},{"key":"797_CR48","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/AOG.0000000000003011","volume":"133","author":"FG Cunningham","year":"2019","unstructured":"Cunningham FG, Byrne JJ, Nelson DB. Peripartum cardiomyopathy. Obstet Gynecol. 2019;133:167\u201379.","journal-title":"Obstet Gynecol"},{"key":"797_CR49","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1213\/ANE.0000000000002530","volume":"126","author":"L Leffert","year":"2018","unstructured":"Leffert L, Butwick A, Carvalho B, Arendt K, Bates SM, Friedman A, et al. The society for obstetric anesthesia and perinatology consensus statement on the anesthetic management of pregnant and postpartum women receiving thromboprophylaxis or higher dose anticoagulants. Anesth Analg. 2018;126:928\u201344.","journal-title":"Anesth Analg"},{"issue":"8","key":"797_CR50","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1007\/s00392-017-1090-5","volume":"106","author":"David Duncker","year":"2017","unstructured":"Duncker D, Westenfeld R, Konrad T, Pfeffer T, Correia de Freitas CA, Pfister R, Thomas D, Furnkranz A, Andrie RP, Napp A, Schmitt J, Karolyi L, Wakili R, Hilfiker-Kleiner D, Bauersachs J, Veltmann C. Risk for life-threatening arrhythmia in newly diagnosed peripartum cardiomyopathy with low ejection fraction: a German multi-centre analysis Clinical research in cardiology : official journal of the German Cardiac Society 2017;106:582\u2013589.","journal-title":"Clinical Research in Cardiology"},{"key":"797_CR51","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1161\/CIRCEP.114.001517","volume":"7","author":"AD Enriquez","year":"2014","unstructured":"Enriquez AD, Economy KE, Tedrow UB. Contemporary management of arrhythmias during pregnancy. Circ Arrhythm Electrophysiol. 2014;7:961\u20137.","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"797_CR52","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ccep.2015.03.010","volume":"7","author":"MC Honigberg","year":"2015","unstructured":"Honigberg MC, Givertz MM. Arrhythmias in peripartum cardiomyopathy. Cardiac electrophysiology clinics. 2015;7:309\u201317.","journal-title":"Cardiac electrophysiology clinics"},{"key":"797_CR53","doi-asserted-by":"crossref","first-page":"7373610","DOI":"10.1155\/2018\/7373610","volume":"2018","author":"B Kovacs","year":"2018","unstructured":"Kovacs B, Reek S, Krasniqi N, Eriksson U, Duru F. Extended use of the wearable cardioverter-defibrillator: which patients are most likely to benefit? Cardiol Res Pract. 2018;2018:7373610.","journal-title":"Cardiol Res Pract"}],"container-title":["Current Treatment Options in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11936-019-0797-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11936-019-0797-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11936-019-0797-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,8]],"date-time":"2020-12-08T01:08:17Z","timestamp":1607389697000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11936-019-0797-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":53,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["797"],"URL":"https:\/\/doi.org\/10.1007\/s11936-019-0797-1","relation":{},"ISSN":["1092-8464","1534-3189"],"issn-type":[{"value":"1092-8464","type":"print"},{"value":"1534-3189","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"9 December 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Shilpa Sharma declares no conflict of interest.Sunu S. Thomas declares no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"83"}}